Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

[Image from Dove Press] A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study’s abstract, medication ...